A randomised trial comparing preoperative administration of single-dose kefazolin to kefazolin plus metronidazole as prophylactic antibiotics at caesarean section
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i6.1081Keywords:
sepsis, infection, PregnancyAbstract
Background. Caesarean section is a life-saving procedure which is associated with high rates of maternal and neonatal complications. It has been estimated that globally, 29.7 million births occur by caesarean section annually. The risk of postpartum infection is estimated to be five to ten times higher compared with normal vaginal delivery. Pregnancy-related sepsis was listed as a top-six cause of maternal mortality in the South African Saving Mothers report between 2017 and 2019. Multiple trials have been conducted in an attempt to optimise administration of prophylactic antibiotics in an effort to reduce postpartum infection and maternal sepsis, and current practice guidelines suggest that there is sufficient evidence that extended-spectrum antibiotics, in combination with kefazolin, result in reduction of postpartum infections.
Objectives. To investigate the effect of perioperative administration of kefazolin alone compared with kefazolin plus metronidazole on postpartum infection in women undergoing caesarean section at Kalafong Provincial Tertiary Hospital, Pretoria, South Africa.
Method. All patients undergoing emergency or elective caesarean section were randomised and then sequentially numbered in opaque sealed envelopes, which were placed in the caesarean section operating theatre. The intervention group received kefazolin and a sealed envelope with metronidazole. The control group received kefazolin and a sealed envelope with normal saline.
Results. A total of 57/1 010 patients (5.64%) had surgical site infections, of which 27 (5.33%) were in the control group, and 30 (5.96%) were in the intervention group (p=0.66). Two patients in each arm (0.40% in the intervention arm and 0.39% in the control arm) underwent laparotomy procedures, while three women (0.60%) in the intervention arm and four women (0.79%) in the control arm underwent hysterectomy procedures. There were no statistically significant differences in all the measured secondary outcomes between the two groups.
Conclusion. The overall sepsis rate in this study was 5.64%. Postpartum infection is multifactorial and there are multiple factors that can be addressed in strengthening the sepsis care bundle. We do not recommend the addition of metronidazole to kefazolin as prophylaxis at caesarean section.
References
Boerma T, Ronsmans C, Melesse DY, et al. Global epidemiology of use of and disparities in caesarean sections. Lancet 2018;392(10155):1341-1348. https://doi.org/10.1016/s0140-6736(18)31928-7
Gibbs RS. Clinical risk factors for puerperal infection. Obstet Gynecol 1980;55(Suppl 5):178s-184s.
https:/doi.org/10.1097/00006250-198003001-00045
Mhlanga PRE, Fawcus PS, Chauke PL, Baloyi DK, Makinde DM, Mbeki DM. Saving Mothers annual report for 2021. Pretoria: South African National Department of Health, 2021.
Sood GA, Argani CB, Ghanem KGA, Perl TMC, Sheffield JSB. Infections complicating cesarean delivery. Curr Opin Infect Dis 2018;31(4):368-376. https:/doi.org/10.1097/QCO.0000000000000472
Weinstein RA, Boyer KM. Antibiotic prophylaxis for cesarean delivery – when broader is better. N Engl
J Med 2016;375(13):1284-1286. https://doi.org/10.1056/NEJMe1610010
Turner MJ. Maternal sepsis is an evolving challenge. Int J Gynecol Obstet 2019;146(1):39-42. https://
doi.org/10.1002/ijgo.12833
American College of Obstetricians and Gynaecologists. ACOG practice bulletin no. 199. Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2018;132(3):e103-e119. https://doi. org/10.1097/aog.0000000000002833
Williams MJ, Carvalho Ribeiro do Valle C, Gyte GM. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database Syst Rev 2021;3(3):CD008726. https://doi.org/10.1002/14651858.CD008726.pub3
Smaill FM, Grivell RM. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014;2014(10):Cd007482. https://doi. org/10.1002/14651858.CD007482.pub3
Meyer NL, Hosier KV, Scott K, Lipscomb GH. Cefazolin versus cefazolin plus metronidazole for antibiotic prophylaxis at cesarean section. South Med J 2003;96(10):992-995. https://doi.org/10.1097/01. Smj.0000060570.51934.14
Taylor M, Jenkins SM, Pillarisetty LS. Endometritis. Statpearls. Treasure Island (FL): StatPearls Publishing, 2023.
Löfmark S, Edlund C, Nord CE. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin Infect Dis 2010; 50(Suppl 1):S16-S23. https://doi.org/10.1086/647939
Johnson AN, Buchmann EJ. Puerperal infection after caesarean section at Chris Hani Baragwanath Academic Hospital, Johannesburg. S Afr J Obstetr Gynaecol 2012;18(3):90-91. https://doi.org/10.7196/ SAJOG.559
MoodliarS,MoodleyJ,EsterhuizenTM.Complicationsassociatedwithcaesareandeliveryinasetting with high HIV prevalence rates. Euro J Obstet Gynecol Reproduct Biol 2007;131(2):138-145. https:// doi.org/10.1016/j.ejogrb.2006.05.004
Temenu AV. Post caesarean section wound infections at Rahima Moosa Mother and Child Hospital. Johannesburg: PhD thesis, University of the Witwatersrand, 2019.
Kvalvik SA, Rasmussen S, Thornhill HF, Baghestan E. Risk factors for surgical site infection following cesarean delivery: A hospital-based case-control study. Acta Obstet Gynecol Scand 2021;100(12):2167- 2175. https://doi.org/10.1111/aogs.14235
Darnal N, Dangal G. Maternal and fetal outcome in emergency versus elective caesarean section. J Nepal Health Res Counc 2020;18(2):186-189. https://doi.org/10.33314/jnhrc.v18i2.2093
Suwal A, Shrivastava VR, Giri A. Maternal and fetal outcome in elective versus emergency cesarean section. J Nepal Med Assoc 2013;52(192):563-566.
Thakur V, Chiheriya H , Thakur A, Mourya S. Study of maternal and fetal outcome in elective and emergency caesarean section. Int J Med Res Rev 2015;3(11):1300-1305. https://doi.org/10.17511/ ijmrr.2015.i11.236.
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev 2020;16(5):442-449. https://doi.org/10.2174/1573399815666191024085838
Downloads
Published
Issue
Section
License
Copyright (c) 2024 R Lamfel, L Snyman, L Seopela , G Jahn, P Becker
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
